TLR2 and cancer: Therefore, if further studies lead to distinguishing the TLR2 heterodimers involved in cancer progression from those involved in protective immune responses, the use of these small molecule TLR2 inhibitors will allow inhibiting those TLR2 signaling pathways that exert a detrimental role on cancer progression, while sparing those that favor anti-tumor immune responses.